XGene Data Integrity Lens™

01 Article Cover Alcoa Data Completeness Deletion Risk 1024x576

ALCOA+ Data Completeness — The Deletion Problem FDA Finds First

FDA investigators are trained to look for what is missing from your data records before they look at what is present — and the deletion of failed runs, rejected results, or inconvenient data points is the data integrity violation that most reliably transforms a 483 observation into a Warning Letter. That sentence reflects one of

ALCOA+ Data Completeness — The Deletion Problem FDA Finds First Read More »